Earnings call transcript: Pampa Energía Q3 2026 misses estimates as capex weighs

Pampa Energía’s Q3 2026 EPS was $0.10 versus a $2.50 forecast, while revenue of $790 million missed estimates by 6.14%; shares fell 2.55% to $68 after hours. Adjusted EBITDA rose 23% year over year to $398 million, but capex surged 85% to $585 million and free cash flow was negative $388 million, lifting net leverage to 1.7x from 1.4x. Management expects free cash flow to remain negative near term and turn positive in 2028, with no near-term buybacks or dividends planned.

Analysis

The key issue is cash conversion, not operating momentum: stronger EBITDA is being absorbed by growth capex, hedge collateral and transport prepayments, while leverage is rising. That makes the “cheap” earnings multiple a weak anchor until investors can separate recurring operating earnings from hedge and financing noise and see a credible funding path. The near-term asymmetry is unfavorable for PAM: management expects another year of negative free cash flow, no distributions, and leverage nearer the top of its stated range. The urea project’s turnkey protections may limit construction-cost exposure, but do not remove funding, schedule or demand risk; financing is still under negotiation, so treat closure as a catalyst to verify rather than a completed de-risking event.

There is a real counterweight over the next 1–3 months and into 2027: power-market liberalization and added gas transport could improve captured margins and support TGS’s tariff-recovered expansion. But the benefit is not equivalent to near-term cash generation at PAM. Dispatch, weather, contracting and regulatory implementation determine the realized uplift; management did not quantify an integrated offset to weaker cash flow. Over 6–18 months, Rincón de Aranda ramp-up could lower unit costs, while the large urea build and associated spending keep capital intensity high. The modest initial share reaction despite the earnings miss may reflect prior caution, but oversold screens and analyst targets are not evidence of a floor.

Contrarian view: the market may be over-penalizing a temporary investment trough, given EBITDA growth and prospective power-margin capture. That case needs confirmation in cash flow, not just EBITDA. Falsifiers for the cautious view are timely project financing, leverage stabilizing below 2.0x, and improving free cash flow excluding one-off collateral/prepayments; slippage or further hedge cash calls would reinforce it.

Key Decisions for Investors

• Keep PAM underweight / avoid adding solely on the low-multiple or oversold narrative. Reassess after the next financing and cash-flow disclosures; require evidence that project financing closes and that operating cash generation is covering a larger share of investment needs.
• Consider a modest relative-value pair: long TGS versus short PAM, reflecting potential tariff recovery on TGS expansion capex against PAM’s broader funding and reinvestment burden. Keep sizing conservative; confirm TGS tariff mechanics, recovery timing and project commitments before entry, and exit if recovery is delayed or PAM leverage stabilizes while cash flow improves.
• For a 1–3 month catalyst watch, track urea project-finance execution, hedge collateral/settlement disclosures, and PAM net leverage. A financing delay, leverage approaching or exceeding 2.0x, or further negative free cash flow without a clear one-off explanation would strengthen the cautious stance; successful financing and leverage stabilization would weaken it.
• Do not underwrite the 2027 power-margin uplift at face value yet. Verify realized margins, contracted volumes and dispatch after the rule changes and new transport capacity come online; weaker-than-expected capture or adverse regulatory revisions would invalidate the prospective earnings offset.